bufalin has been researched along with Astrocytoma, Grade IV in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, A; Han, M; Huang, B; Huang, Q; Li, X; Qiu, C; Sun, T; Wang, F; Wang, J; Wang, X; Xu, R; Xu, Y; Zhang, X; Zhao, P | 1 |
| Ding, Y; Lan, YL; Lou, JC; Ma, BB; Wang, X; Xing, JS; Zhang, B; Zou, S; Zou, YJ | 1 |
2 other study(ies) available for bufalin and Astrocytoma, Grade IV
| Article | Year |
|---|---|
Bufalin enhances radiosensitivity of glioblastoma by suppressing mitochondrial function and DNA damage repair.
Topics: Antineoplastic Agents; Bufanolides; Cell Line, Tumor; Cell Proliferation; DNA Breaks, Double-Stranded; DNA Damage; DNA Repair; G2 Phase Cell Cycle Checkpoints; Glioblastoma; Humans; M Phase Cell Cycle Checkpoints; Membrane Potential, Mitochondrial; Mitochondria; Radiation Tolerance | 2017 |
The sodium pump α1 subunit regulates bufalin sensitivity of human glioblastoma cells through the p53 signaling pathway.
Topics: Antineoplastic Agents; Apoptosis; Bufanolides; Cell Line, Tumor; Cell Proliferation; China; DNA Damage; Glioblastoma; Glioma; Humans; Oxidative Stress; Signal Transduction; Sodium-Potassium-Exchanging ATPase; Tumor Suppressor Protein p53 | 2019 |